The considerable variability in intra-patient and inter-patient immunogenicity of melanoma reflects the evolutionary process between the immune system and melanoma cells, which cannot be limited to PD-1/PD-L1 interaction but must be viewed as an evolutionary process defined by a different phenotypic and functional subset of cells. Here, CD274 is linked to melanoma.